Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Van Buuren, Henk R" or (type any "bookEditor issueEditor" and editor="Van Buuren, Henk R")

Add to list
- Journal Article
- A1
- open access
Factors associated with progression and outcomes of early stage primary biliary cholangitis

Nikolaos K Gatselis, Jorn C Goet, Kalliopi Zachou, Willem J Lammers, Harry LA Janssen, Gideon Hirschfield, Christophe Corpechot, Keith D Lindor, Pietro Invernizzi, Marlyn J Mayo, et al.

(2020) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 18(3). p.684-692
Add to list
- Conference Paper
- C3
Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response

Rozanne de Veer, Maren H Harms, Christophe Corpechot, Willem J Lammers, Douglas Thorburn, Pietro Invernizzi, Harry LA Janssen, Pier Maria Battezzati, Frederik Nevens, Keith D Lindor, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.783A-785A
Add to list
- Conference Paper
- C3
Ursodeoxycholic acid treatment-induced globe score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis

Rozanne de Veer, Maren H Harms, Jorn Goet, Christophe Corpechot, Douglas Thorburn, Pietro Invernizzi, Willem J Lammers, Harry LA Janssen, Pier Maria Battezzati, Frederik Nevens, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.776A-777A
Add to list
- Conference Paper
- C3
Derivation of a machine learning model to predict clinical outcome in patients with primary biliary cholangitis

Jorn Goet, Surain Roberts, Gideon Hirschfield, Pietro Invernizzi, Marco Carbone, Palak Trivedi, Christophe Corpechot, Harry LA Janssen, Rozanne de Veer, Willem J Lammers, et al.

(2019) HEPATOLOGY. 70(suppl. 1). p.760A-761A
Add to list
- Conference Paper
- C3
Validation of the Amsterdam-Oxford survival prediction model in primary sclerosing cholangitis in a tertiary center setting

Jorn Goet, Annarosa Floreani, Xavier Verhelst (UGent) , Nora Cazzagon, Lisa Perini, Willem J Lammers, Adriaan Van Der Meer, Annemarie C De Vries, Henk R van Buuren and Bettina E Hansen

(2018) HEPATOLOGY. 68(suppl. 1). p.1076A-1077A
Add to list
Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis : risk factors and time trends in incidence and outcome

Maren H Harms, Willem J Lammers, Douglas Thorburn, Christophe Corpechot, Pietro Invernizzi, Harry LA Janssen, Pier M Battezzati, Frederik Nevens, Keith D Lindor, Annarosa Floreani, et al.

(2018) AMERICAN JOURNAL OF GASTROENTEROLOGY. 113(2). p.254-264
Add to list
Milder disease stage in patients with primary biliary cholangitis over a 44-year period : a changing natural history

Fiorella Murillo Perez, Jorn C Goet, Willem J Lammers, Aliya Gulamhusein, Henk R van Buuren, Cyriel Y Ponsioen, Marco Carbone, Andrew Mason, Christophe Corpechot, Pietro Invernizzi, et al.

(2018) HEPATOLOGY. 67(5). p.1920-1930
Add to list
- Conference Paper
- C3
Alkaline phosphatase normalization is associated with a decreased risk for liver transplantation and death in patients with primary biliary cholangitis

Carla Fiorella Murillo Perez, Aliya Gulamhusein, Christophe Corpechot, Adriaan Van der Meer, Henk R Van Buuren, Pietro Invernizzi, Palak Trivedi, Frederik Nevens, Marlyn J Mayo, Pier Maria Battezzati, et al.

(2018) HEPATOLOGY. 68(suppl. 1). p.1085A-1086A
Add to list
- Conference Paper
- C3
Time trends in major hepatic complications in primary biliary cholangitis : incidence and transplant-free survival

Maren H Harms, Willem J Lammers, Douglas Thorburn, Christophe Corpechot, Pietro Invernizzi, Harry L Janssen, Pier Maria Battezzati, Frederik Nevens, Keith D Lindor, Annarosa Floreani, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.40A-40A
Add to list
- Conference Paper
- C3
Time-dependent factors associated with diminished transplant-free survival in patients with primary biliary cholangitis and an optimal response to ursodeoxycholic acid after one year of treatment

Willem J Lammers, Jorn C Goet, Marlyn J Mayo, Ann-Arosa Floreani, Pietro Invernizzi, Maren H Harms, Christophe Corpechot, Keith D Lindor, Cyriel Y Ponsioen, Harry L Janssen, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.157A-158A
Add to list
- Conference Paper
- C3
Recurrence of primary biliary cholangitis after liver transplantation affects graft survival : a multi-center study from the Global PBC study group

Aldo J Montano-Loza, Bettina E Hansen, Davide Roccarina, Douglas Thorburn, Palak J Trivedi, Gideon Hirschfield, Christophe Corpechot, Raoul Poupon, Jerome Dumortier, Alexie Bosch, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.163A-164A
Add to list
- Conference Paper
- C3
Moving from early to moderate or advanced biochemical disease stage during follow-up is associated with an increasing risk of clinical events in primary biliary cholangitis patients

Nikolaos K Gatselis, Jorn C Goet, Kalliopi Zachou, Willem J Lammers, Harry L Janssen, Gideon Hirschfield, Christophe Corpechot, Keith D Lindor, Pietro Invernizzi, Marlyn J Mayo, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.169A-170A
Add to list
- Conference Paper
- C3
Bilirubin is predictive of transplant-free survival even within the normal range in primary biliary cholangitis patients

Carla F Murillo Perez, Aliya Gulamhusein, Henk R van Buuren, Willem J Lammers, Jorn C Goet, Cyriel Y Ponsioen, Marco Carbone, Andrew Mason, Christophe Corpechot, Marlyn J Mayo, et al.

(2017) HEPATOLOGY. 66(suppl. 1). p.41A-42A
Add to list
- Conference Paper
- C3
The GLOBE score identifies PBC patients at increased risk of liver transplantation or death during follow-up

Jorn C Goet, Willem J Lammers, Harry L Janssen, Gideon M Hirschfield, Christophe Corpechot, Keith D Lindor, Pietro Invernizzi, Marlyn J Mayo, Pier Maria Battezzati, Frederik Nevens, et al.

(2016) HEPATOLOGY. 64(suppl. 1). p.189A-190A
Add to list
- Conference Paper
- C3
Association between ursodeoxycholic acid therapy and prolonged transplant-free survival among patients with primary biliary cholangitis a number needed to treat analysis

Maren H Harms, Annarosa Floreani, Douglas Thorburn, George N Dalekos, Harry L Janssen, Christophe Corpechot, Pietro Invernizzi, Marlyn J Mayo, Pier Maria Battezzati, Henk R van Buuren, et al.

(2016) HEPATOLOGY. 64(suppl. 1). p.188A-188A

Academic Bibliography

Factors associated with progression and outcomes of early stage primary biliary cholangitis

Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response

Ursodeoxycholic acid treatment-induced globe score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis

Derivation of a machine learning model to predict clinical outcome in patients with primary biliary cholangitis

Validation of the Amsterdam-Oxford survival prediction model in primary sclerosing cholangitis in a tertiary center setting

Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis : risk factors and time trends in incidence and outcome

Milder disease stage in patients with primary biliary cholangitis over a 44-year period : a changing natural history

Alkaline phosphatase normalization is associated with a decreased risk for liver transplantation and death in patients with primary biliary cholangitis

Time trends in major hepatic complications in primary biliary cholangitis : incidence and transplant-free survival

Time-dependent factors associated with diminished transplant-free survival in patients with primary biliary cholangitis and an optimal response to ursodeoxycholic acid after one year of treatment

Recurrence of primary biliary cholangitis after liver transplantation affects graft survival : a multi-center study from the Global PBC study group

Moving from early to moderate or advanced biochemical disease stage during follow-up is associated with an increasing risk of clinical events in primary biliary cholangitis patients

Bilirubin is predictive of transplant-free survival even within the normal range in primary biliary cholangitis patients

The GLOBE score identifies PBC patients at increased risk of liver transplantation or death during follow-up

Association between ursodeoxycholic acid therapy and prolonged transplant-free survival among patients with primary biliary cholangitis a number needed to treat analysis

Contents

Support

Contact